These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 1951035)
1. Compounding nausea aid. Francom M Am Pharm; 1991 Jul; NS31(7):7. PubMed ID: 1951035 [No Abstract] [Full Text] [Related]
2. Stability of dexamethasone sodium phosphate, diphenhydramine hydrochloride, lorazepam, and metoclopramide hydrochloride in portable infusion-pump reservoirs. Stiles ML; Allen LV; Prince SJ; Holland JS Am J Hosp Pharm; 1994 Feb; 51(4):514-7. PubMed ID: 8017420 [No Abstract] [Full Text] [Related]
3. Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone. Kris MG; Gralla RJ; Clark RA; Tyson LB; Fiore JJ; Kelsen DP; Groshen S Cancer Treat Rep; 1985 Nov; 69(11):1257-62. PubMed ID: 3912039 [TBL] [Abstract][Full Text] [Related]
4. Controlling nausea and vomiting in outpatients. Schmitt RM; Keppler G; Kroeker G; Novak-Smith P; Sawyer R Oncol Nurs Forum; 1990; 17(2):277. PubMed ID: 2315193 [No Abstract] [Full Text] [Related]
5. Effective control of cisplatin induced emesis by combination drug regimen. Misra R; Agarwal N Indian J Cancer; 1994 Mar; 31(1):19-22. PubMed ID: 8063331 [TBL] [Abstract][Full Text] [Related]
6. The value of dexamethasone when added to combination drug therapy in the prevention of cisplatin-induced nausea and vomiting, evaluated by time-lapse video technology. Rhinehart SN; Dugan WM; Parashos PJ; Triplett WC; Minnick DJ; Fry MW Prog Clin Biol Res; 1986; 216():407-16. PubMed ID: 3523534 [No Abstract] [Full Text] [Related]
7. Antiemetic therapy for chemotherapy-induced vomiting: metoclopramide, benztropine, dexamethasone, and lorazepam regimen compared with chlorpromazine alone. Marshall G; Kerr S; Vowels M; O'Gorman-Hughes D; White L J Pediatr; 1989 Jul; 115(1):156-60. PubMed ID: 2661789 [TBL] [Abstract][Full Text] [Related]
9. [Evaluation of antiemetic effect of clonazepam, metoclopramide, dexamethasone and diphenhydramine for prevention of cisplatin-induced vomiting]. Hatae M; Nakamura Y; Mitsuo M; Sakurai K; Asano H; Onishi Y; Hokanishi H Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1495-9. PubMed ID: 2389945 [TBL] [Abstract][Full Text] [Related]
10. Comparison of ondansetron-dexamethasone-lorazepam versus metoclopramide-dexamethasone-lorazepam in the control of cisplatin induced emesis. Manusirivithaya S; Chareoniam V; Isariyodom P; Sungsab D J Med Assoc Thai; 2001 Jul; 84(7):966-72. PubMed ID: 11759977 [TBL] [Abstract][Full Text] [Related]
11. [Anti-emetic treatment with metoclopramide and other drugs during CDDP therapy]. Kodama N; Furuse K; Kawahara M; Arai R; Tsuruta S; Hayashi S; Kiyota T Gan To Kagaku Ryoho; 1987 Jan; 14(1):159-64. PubMed ID: 3800403 [TBL] [Abstract][Full Text] [Related]
12. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience. Sorbe BG Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123 [TBL] [Abstract][Full Text] [Related]
13. Lorazepam, diphenhydramine, and haloperidol transdermal gel for rescue from chemotherapy-induced nausea/vomiting: results of two pilot trials. Bleicher J; Bhaskara A; Huyck T; Constantino S; Bardia A; Loprinzi CL; Silberstein PT J Support Oncol; 2008 Jan; 6(1):27-32. PubMed ID: 18257398 [TBL] [Abstract][Full Text] [Related]
14. Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes. Anderson CR; Halford Z; MacKay M Int J Pharm Compd; 2015; 19(4):344-7. PubMed ID: 26625573 [TBL] [Abstract][Full Text] [Related]
15. Comparison of dexamethasone and metoclopramide as antiemetics in children receiving cancer chemotherapy. Basade M; Kulkarni SS; Dhar AK; Sastry PS; Saikia B; Advani SH Indian Pediatr; 1996 Apr; 33(4):321-3. PubMed ID: 8772908 [No Abstract] [Full Text] [Related]
16. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents. Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120 [TBL] [Abstract][Full Text] [Related]
17. Randomized, double-blind, cross-over study comparing prochlorperazine and lorazepam with high-dose metoclopramide and lorazepam for the control of emesis in patients receiving cytotoxic chemotherapy. Bishop JF; Wolf M; Matthews JP; Scott K; Ackland S; Yuen K; Morton C; Hillcoat BL; Cooper IA Cancer Treat Rep; 1987 Nov; 71(11):1007-11. PubMed ID: 3315193 [TBL] [Abstract][Full Text] [Related]
18. The influence of dexamethasone in the decrease of chemotherapy-induced nausea and vomiting. Sarcev T; Secen N; Povazan Dj; Sabo A; Popovic J; Bursac D; Kakas M; Zaric B; Milovancev A J BUON; 2007; 12(2):245-52. PubMed ID: 17600880 [TBL] [Abstract][Full Text] [Related]
19. Prevention of cisplatin-induced delayed emesis: still unsatisfactory. Italian Group for Antiemetic Research. Support Care Cancer; 2000 May; 8(3):229-32. PubMed ID: 10789965 [TBL] [Abstract][Full Text] [Related]
20. Tolerability of the compound ABHR in hospice patients. Weschules DJ J Palliat Med; 2005 Dec; 8(6):1135-43. PubMed ID: 16351526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]